Our lab is using state-of-the-art quantitative mass-spectrometry based proteomics technology to identify chromatin readers for epigenetic histone and DNA modifications. We characterize the (dynamic) complexes that these readers form, we study their biology in (differentiated) stem cells and in different model organisms and we investigate their potential deregulation in cancer.
